These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15832900)

  • 21. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes.
    Stutz B; Ahola AJ; Harjutsalo V; Forsblom C; Groop PH;
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):470-476. PubMed ID: 29501444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-sensitivity C-reactive protein in type 2 diabetic patients with and without the metabolic syndrome.
    Joshi MD; Wala J; Acharya KS; Amayo A
    East Afr Med J; 2008 Apr; 85(4):178-86. PubMed ID: 18700351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
    Anan F; Takahashi N; Nakagawa M; Ooie T; Saikawa T; Yoshimatsu H
    Metabolism; 2005 Apr; 54(4):552-8. PubMed ID: 15798966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.
    Rathcke CN; Johansen JS; Vestergaard H
    Inflamm Res; 2006 Feb; 55(2):53-9. PubMed ID: 16612564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease.
    DeBoer MD; Gurka MJ; Morrison JA; Woo JG
    Int J Obes (Lond); 2016 Sep; 40(9):1353-9. PubMed ID: 27133621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of leukocyte count and hsCRP with metabolic abnormalities in subjects with normal glucose tolerance (CURES - 64).
    Gokulakrishnan K; Deepa R; Sampathkumar R; Balasubramanyam M; Mohan V
    J Assoc Physicians India; 2009 Jan; 57():27-32. PubMed ID: 19753755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance.
    O'Sullivan EP; Ashley DT; Davenport C; Penugonda L; Kelleher G; Devlin N; Crowley R; O'Shea P; Agha A; Thompson CJ; O'Gorman DJ; Smith D
    Metabolism; 2013 Jan; 62(1):34-8. PubMed ID: 22841521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome and C-reactive protein in the general population: JMS Cohort Study.
    Ishikawa S; Kayaba K; Gotoh T; Nakamura Y; Kajii E
    Circ J; 2007 Jan; 71(1):26-31. PubMed ID: 17186974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High sensitivity C-reactive protein (hsCRP): Its relationship with metabolic syndrome and Framingham Risk Score.
    Zahari Sham SY; Hanif E; Thambiah SC; Samsudin IN; Mohd Noor S; Osman M; Abdullah H; Mustaffa K
    Malays J Pathol; 2021 Apr; 43(1):33-40. PubMed ID: 33903303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Water T
    Robinson MD; Mishra I; Deodhar S; Patel V; Gordon KV; Vintimilla R; Brown K; Johnson L; O'Bryant S; Cistola DP
    J Transl Med; 2017 Dec; 15(1):258. PubMed ID: 29258604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study.
    Ngala RA; Awe MA; Nsiah P
    PLoS One; 2018; 13(7):e0197977. PubMed ID: 29975702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men.
    Ueba T; Nomura S; Inami N; Nishikawa T; Kajiwara M; Iwata R; Yamashita K
    J Atheroscler Thromb; 2010 Apr; 17(4):342-9. PubMed ID: 20379056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
    Robins SJ
    Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients.
    Anan F; Masaki T; Kikuchi H; Iwao T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
    Diabetes Res Clin Pract; 2010 Feb; 87(2):233-9. PubMed ID: 19931932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipid concentrations among persons with spinal cord injury - a systematic review and meta-analysis of the literature.
    Gilbert O; Croffoot JR; Taylor AJ; Nash M; Schomer K; Groah S
    Atherosclerosis; 2014 Feb; 232(2):305-12. PubMed ID: 24468143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein heterogeneity in persons with Spinal Cord Injury: a model of prolonged sitting and restricted physical activity.
    La Fountaine MF; Cirnigliaro CM; Emmons RR; Kirshblum SC; Galea M; Spungen AM; Bauman WA
    Lipids Health Dis; 2015 Jul; 14():81. PubMed ID: 26215870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.
    Sesti G; Sciacqua A; Cardellini M; Marini MA; Maio R; Vatrano M; Succurro E; Lauro R; Federici M; Perticone F
    Diabetes Care; 2005 Jan; 28(1):120-5. PubMed ID: 15616244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.
    Bulcão C; Ribeiro-Filho FF; Sañudo A; Roberta Ferreira SG
    Am J Cardiovasc Drugs; 2007; 7(3):219-24. PubMed ID: 17610348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.